Health
Model simulations show no need for DEX dose adjustments in COVID-19 patients with liver disease – News-Medical.net
A recent study sed PBPK modeling to demonstrate the use of DEX PKs for the treatment of COVID-19 in patients with liver impairment….
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in December 2019. Studies have shown that between 3% to 8% of coronavirus disease 2019 (COVID-19) patients have pre-existing chronic liver disease (LD)….
Continue Reading
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News24 hours agoRainbow Beach surfer’s untold 7/7 story
-
Business21 hours agoInvested $10,000 in Westpac shares 2 years ago? Guess how much you’ve already banked!
-
Noosa News14 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years